No abstract available
MeSH terms
-
Antiviral Agents / administration & dosage*
-
Biomarkers / blood
-
Drug Resistance
-
Drug Therapy, Combination
-
Genotype
-
Hepacivirus / genetics
-
Hepatitis C, Chronic / diagnosis
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / virology
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage
-
Interferons / administration & dosage*
-
Polyethylene Glycols / administration & dosage
-
RNA, Viral / blood
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Ribavirin / administration & dosage*
-
Time Factors
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Biomarkers
-
Interferon alpha-2
-
Interferon-alpha
-
RNA, Viral
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
Interferons
-
peginterferon alfa-2b
-
peginterferon alfa-2a